{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:08:46Z","timestamp":1788322126895,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijantimicag.2019.08.018","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T23:26:13Z","timestamp":1567207573000},"page":"572-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study"],"prefix":"10.1016","volume":"54","author":[{"given":"D.","family":"Echeverria-Esnal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sorli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Prim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Conde-Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mateu-De Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Martin-Ontiyuelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-5459","authenticated-orcid":false,"given":"J.P.","family":"Horcajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the enterococcus: beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ijcp.12754","article-title":"Enterococcal bloodstream infection. Design and validation of a mortality prediction rule","volume":"70","author":"P\u00e9rez-Garc\u00eda","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0003","series-title":"Annual report of the European Antimicrobial REsistance Surveillance Network (EARS-Net)","article-title":"Surveillance of antimicrobial resistance in Europe 2016","year":"2017"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0004","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1017\/S0950268818002479","article-title":"Enterococcal bacteraemia: predictive and prognostic risk factors for ampicillin resistance","volume":"146","author":"Matsumura","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/civ560","article-title":"Epidemiology, management, and risk-adjusted mortality of ICU-acquired enterococcal bacteremia","volume":"61","author":"Ong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0006","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0007","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/1469-0691.12028","article-title":"The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System","volume":"19","author":"De Kraker","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0008","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/jac\/dkn360","article-title":"Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals","volume":"62","author":"Lester","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10096-009-0830-5","article-title":"Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia \u2013 a five-year retrospective review","volume":"29","author":"McBride","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijantimicag.2008.04.026","article-title":"Virulence and antimicrobial resistance in clinical Enterococcus faecium","volume":"32","author":"Billstr\u00f6m","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0011","series-title":"Data from the ECDC Surveillance Atlas \u2013 antimicrobial resistance","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0012","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14787210.2014.870886","article-title":"Antibiotic resistance in Enterococcus faecium clinical isolates","volume":"12","author":"Cattoir","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0013","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01289-13","article-title":"Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia","volume":"58","author":"Balli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1060028014556879","article-title":"Vancomycin-resistant enterococcal bacteremia pharmacotherapy","volume":"49","author":"Patel","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12879-014-0687-9","article-title":"Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis","volume":"14","author":"Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0016","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0017","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0974-777X.176141","article-title":"Molecular characterization of virulence genes in vancomycin-resistant and vancomycin-sensitive enterococci","volume":"8","author":"Biswas","year":"2016","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0018","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/519470","article-title":"Limitations of vancomycin in the management of resistant staphylococcal infections","volume":"45","author":"Kollef","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0019","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dkf245","article-title":"The in vitro and in vivo antibacterial characterization of vancomycin and linezolid against vancomycin-susceptible and -resistant enterococci","volume":"50","author":"Miyazaki","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0020","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0924-8579(09)70569-2","article-title":"New antibiotics: optimal use in current clinical practice","volume":"34","author":"Karageorgopoulos","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1741-7015-12-40","article-title":"Classification of healthcare-associated infection: a systematic review 10 years after the first proposal","volume":"12","author":"Cardoso","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0022","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","article-title":"International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections","volume":"140","author":"Paterson","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0024","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0026","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0027","series-title":"Manual of clinical microbiology 2003","author":"Murray","year":"2003"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0028","series-title":"EUCAST clinical breakpoints","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0029","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eimc.2009.06.011","article-title":"Caracter\u00edsticas cl\u00ednicas diferenciales entre las bacteriemias por Enterococcus faecalis y Enterococcus faecium","volume":"28","author":"Conde-Est\u00e9vez","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0030","series-title":"Bloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infection)","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0031","doi-asserted-by":"crossref","first-page":"e74734","DOI":"10.1371\/journal.pone.0074734","article-title":"Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes","volume":"8","author":"Gudiol","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0032","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/318717","article-title":"Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia","volume":"32","author":"Caballero-Granado","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0033","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/cit223","article-title":"Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post hoc analysis of a prospective cohort","volume":"57","author":"Pe\u00f1a","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0034","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijid.2014.02.012","article-title":"Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study","volume":"26","author":"Billington","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0036","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1157\/13109986","article-title":"An\u00e1lisis de 182 episodios de bacteriemia por enterococo: estudio de la epidemiolog\u00eda, microbiolog\u00eda y evoluci\u00f3n cl\u00ednica","volume":"25","author":"Mart\u00ednez-Odriozola","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1469-0691.12236","article-title":"Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006\u20132009: a population-based cohort study","volume":"20","author":"Pinholt","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0038","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13756-017-0231-y","article-title":"Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study","volume":"6","author":"Zhang","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0039","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jiac.2015.04.001","article-title":"Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: an eight-year retrospective comparison study","volume":"21","author":"Hamada","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0040","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/cid\/ciy749","article-title":"Pharmacodynamic analysis of daptomycin-treated enterococcal bacteremia: it is time to change the breakpoint","volume":"68","author":"Avery","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0041","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/cid\/cix1127","article-title":"Busting the myth of \u201cstatic vs cidal\u201d: a systemic literature review","volume":"66","author":"Wald-Dickler","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.018_bib0042","article-title":"Early switching of antibiotic therapy from intravenous to oral using a combination of education, pocket-sized cards and switch advice: a practical intervention resulting in a reduction in length of hospital stay","author":"Mouwen","year":"2019","journal-title":"Int J Antimicrob Agents"}],"updated-by":[{"DOI":"10.1016\/j.ijantimicag.2021.106455","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T15:55:26Z","timestamp":1656863726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0924857919302365"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.018","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijantimicag.2021.106455","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}